GB202000121D0 - Compounds and conjugates - Google Patents

Compounds and conjugates

Info

Publication number
GB202000121D0
GB202000121D0 GBGB2000121.0A GB202000121A GB202000121D0 GB 202000121 D0 GB202000121 D0 GB 202000121D0 GB 202000121 A GB202000121 A GB 202000121A GB 202000121 D0 GB202000121 D0 GB 202000121D0
Authority
GB
United Kingdom
Prior art keywords
conjugates
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2000121.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MedImmune Ltd
Original Assignee
MedImmune Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MedImmune Ltd filed Critical MedImmune Ltd
Priority to GBGB2000121.0A priority Critical patent/GB202000121D0/en
Publication of GB202000121D0 publication Critical patent/GB202000121D0/en
Priority to AU2020242747A priority patent/AU2020242747A1/en
Priority to CA3130174A priority patent/CA3130174A1/en
Priority to PCT/EP2020/056761 priority patent/WO2020187721A1/en
Priority to MX2021010477A priority patent/MX2021010477A/en
Priority to KR1020217029628A priority patent/KR20210139270A/en
Priority to ES20711857T priority patent/ES2967878T3/en
Priority to EP20711857.1A priority patent/EP3938372B1/en
Priority to SG11202108900WA priority patent/SG11202108900WA/en
Priority to EA202192003A priority patent/EA202192003A1/en
Priority to BR112021018260A priority patent/BR112021018260A2/en
Priority to JP2021555569A priority patent/JP2022524880A/en
Priority to US17/439,639 priority patent/US20220160881A1/en
Priority to CN202080021224.4A priority patent/CN113631560A/en
Priority to ZA2021/05931A priority patent/ZA202105931B/en
Priority to IL286326A priority patent/IL286326A/en
Ceased legal-status Critical Current

Links

GBGB2000121.0A 2019-03-15 2020-01-06 Compounds and conjugates Ceased GB202000121D0 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
GBGB2000121.0A GB202000121D0 (en) 2020-01-06 2020-01-06 Compounds and conjugates
CN202080021224.4A CN113631560A (en) 2019-03-15 2020-03-13 Azetidino-benzodiazepine dimers and conjugates comprising same for the treatment of cancer
ES20711857T ES2967878T3 (en) 2019-03-15 2020-03-13 Azetidobenzodiazepine dimers and conjugates comprising them for use in the treatment of cancer
SG11202108900WA SG11202108900WA (en) 2019-03-15 2020-03-13 Azetidobenzodiazepine dimers and conjugates comprising them for use in the treatment of cancer
PCT/EP2020/056761 WO2020187721A1 (en) 2019-03-15 2020-03-13 Azetidobenzodiazepine dimers and conjugates comprising them for use in the treatment of cancer
MX2021010477A MX2021010477A (en) 2019-03-15 2020-03-13 Azetidobenzodiazepine dimers and conjugates comprising them for use in the treatment of cancer.
KR1020217029628A KR20210139270A (en) 2019-03-15 2020-03-13 Azetidobenzodiazepine dimers and conjugates comprising the same for use in the treatment of cancer
AU2020242747A AU2020242747A1 (en) 2019-03-15 2020-03-13 Azetidobenzodiazepine dimers and conjugates comprising them for use in the treatment of cancer
EP20711857.1A EP3938372B1 (en) 2019-03-15 2020-03-13 Azetidobenzodiazepine dimers and conjugates comprising them for use in the treatment of cancer
CA3130174A CA3130174A1 (en) 2019-03-15 2020-03-13 Azetidobenzodiazepine dimers and conjugates comprising them for use in the treatment of cancer
EA202192003A EA202192003A1 (en) 2020-01-06 2020-03-13 AZETIDOBENZODIAZEPINE DIMERS AND CONJUGATES CONTAINING THEM FOR USE IN CANCER TREATMENT
BR112021018260A BR112021018260A2 (en) 2019-03-15 2020-03-13 Azetidobenzodiazepine dimers and conjugates comprising the same for use in the treatment of cancer
JP2021555569A JP2022524880A (en) 2019-03-15 2020-03-13 Azetidebenzodiazepine dimer and complex containing it for use in the treatment of cancer
US17/439,639 US20220160881A1 (en) 2019-03-15 2020-03-13 Azetidobenzodiazepine dimers and conjugates comprising them for use in the treatment of cancer
ZA2021/05931A ZA202105931B (en) 2019-03-15 2021-08-18 Azetidobenzodiazepine dimers and conjugates comprising them for use in the treatment of cancer
IL286326A IL286326A (en) 2019-03-15 2021-09-13 Azetidobenzodiazepine dimers and conjugates comprising them for use in the treatment of cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2000121.0A GB202000121D0 (en) 2020-01-06 2020-01-06 Compounds and conjugates

Publications (1)

Publication Number Publication Date
GB202000121D0 true GB202000121D0 (en) 2020-02-19

Family

ID=69527978

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2000121.0A Ceased GB202000121D0 (en) 2019-03-15 2020-01-06 Compounds and conjugates

Country Status (2)

Country Link
EA (1) EA202192003A1 (en)
GB (1) GB202000121D0 (en)

Also Published As

Publication number Publication date
EA202192003A1 (en) 2021-12-28

Similar Documents

Publication Publication Date Title
IL286291A (en) Compounds and conjugates thereof
IL287391A (en) Amatoxin antibody-drug conjugates and uses thereof
SG11202101719PA (en) Antibody-drug conjugate and application thereof
IL284974A (en) Anti-cd228 antibodies and antibody-drug conjugates
IL286847A (en) Hsp90-binding conjugates and formulations thereof
SG11202101517PA (en) Isoquinoline-steroid conjugates and uses thereof
EP4096657A4 (en) Compounds and uses thereof
IL304565A (en) Immunostimulatory compounds and conjugates
IL276546A (en) Hydrophobic auristatin f compounds and conjugates thereof
IL277791A (en) Hsp90-targeting conjugates and formulations thereof
IL291312A (en) Anti-ptcra antibody-drug conjugates and uses thereof
IL287917A (en) Hyaluronan conjugates and uses thereof
IL304332A (en) Lrrc15 antibodies and conjugates thereof
GB201902182D0 (en) Pyrrolobenzodiazepines and conjugates thereof
IL311521A (en) Egfrviii-targeted compounds and uses thereof
IL310778A (en) Sirp-alpha antibodies and conjugates
GB2594753B (en) Antibody-drug conjugates
GB202000121D0 (en) Compounds and conjugates
GB201820864D0 (en) Antibody-drug conjugates
IL308811A (en) Neodegrader conjugates
GB201903541D0 (en) Compounds and conjugates
GB201903535D0 (en) Compounds and conjugates
GB202210058D0 (en) Conjugates
GB202105186D0 (en) Pyrrolobenzodiazepine conjugates
GB202105187D0 (en) Pyrrolobenzodiazepine conjugates

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)